Hosted on MSN2mon
Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more poundsZepbound (tirzepatide), manufactured by Fortune 500 firm Eli Lilly & Co., bested competitor Wegovy (semaglutide), a product of Global 500 company Novo Nordisk, in a recent randomized clinical ...
According to leading data and analytics company GlobalData, Eli Lilly’s Zepbound (tirzepatide) is poised to surpass Novo Nordisk’s Wegovy (semaglutide), despite expectations for continued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback